Institute For Safe Medication Practices

Institute For Safe Medication Practices, a 501(c)(3) non-profit organization based in Doylestown, Pennsylvania, delivers medication safety newsletters, error-prevention data services, and clinical decision-support tools to federal healthcare agencies as a prime contractor on full-and-open procurements. ISMP does not hold SBA set-aside certifications and competes exclusively in unrestricted procurements; recent awards carry no set-aside designations.

ISMP's capability footprint centers on acute-care medication safety alerting, drug-name confusion error prevention, and medication error surveillance products delivered through subscription newsletters and data-access platforms. Representative prime work includes a $3.2 million purchase order from the Food and Drug Administration (awarded September 2025, completion September 2030) for access to medication error data, products, and services under the SafeMed Use platform; a $132.9 thousand Defense Health Agency purchase order (awarded April 2022, completion April 2027) for subscriptions to the Acute Care Medication Safety Alert and Community and Ambulatory Care Edition newsletters; and recurring blanket purchase agreement call orders from the Department of Veterans Affairs Veterans Integrated Service Network 12 for acute care newsletter subscriptions, including awards of $97,266 (April 2022–March 2023), $19,436 (April 2023–March 2024), $20,020.80 (April 2024–May 2027), and $20,622.80 (April 2025–March 2026).

Customer concentration is split between high-dollar and high-volume relationships. The Food and Drug Administration anchors 99% of combined potential value across all awards ($3.8 million of $5.2 million total), while the Department of Veterans Affairs Veterans Integrated Service Network 12 dominates award count with 14 awards ($458 thousand combined potential value). The Defense Health Agency and Veterans Integrated Service Network 10 round out the top four customers. ISMP has served ten distinct federal agencies in recent years, with no customer concentration approaching program-level dependency outside the FDA relationship.

ISMP holds a single-award Blanket Purchase Agreement (36C25221A0011) with the VA established April 1, 2021, with a $97,266 original ceiling; five task orders have drawn $168 thousand in combined potential value since award. Most work is performed in Pennsylvania locations including Plymouth Meeting, Horsham, and Doylestown, with services delivered to VA facilities in southeastern Pennsylvania and southern New Jersey and to federal healthcare networks nationwide.

Activity has remained modest and flat — one to two awards per year over the past five years — with a combined potential value of $5.2 million obligated across 54 awards since 2003. Three awards ($164 thousand combined potential value) face ultimate completion within the next twenty-four months and will face recompete risk in that window. ISMP subcontracts infrequently (6% of recent awards); a single named sub engagement is a $132.9 thousand subcontract to Northwestern University (awarded February 2024) for assessing the effectiveness of text enhancements to prevent drug name confusion errors. As a Patient Safety Organization, ISMP derives its federal posture from specialized clinical expertise in medication error prevention rather than from contracting vehicle positioning or set-aside access.